163 related articles for article (PubMed ID: 37084305)
1. Importance of the SARS-CoV-2 genome and spike protein in the immunopathogenesis of COVID-19 and in the efficacy of vaccines.
Jiménez-Morales S; Pérez-Amado CJ; Montúfar-Robles I; Fragoso JM; Aranda-Uribe IS; Ramos-Puga DA; Martínez-Flores ÁE; Ramírez-Bello J
Cir Cir; 2023; 91(2):268-276. PubMed ID: 37084305
[TBL] [Abstract][Full Text] [Related]
2. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
[TBL] [Abstract][Full Text] [Related]
3. Mutations in spike protein and allele variations in ACE2 impact targeted therapy strategies against SARS-CoV-2.
Shu CJ; Huang X; Tang HH; Mo DD; Zhou JW; Deng C
Zool Res; 2021 Mar; 42(2):170-181. PubMed ID: 33738989
[TBL] [Abstract][Full Text] [Related]
4. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
Kuba K; Yamaguchi T; Penninger JM
Front Immunol; 2021; 12():732690. PubMed ID: 35003058
[TBL] [Abstract][Full Text] [Related]
6. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
Front Immunol; 2020; 11():1880. PubMed ID: 32973779
[TBL] [Abstract][Full Text] [Related]
7. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
Bui NN; Lin YT; Huang SH; Lin CW
Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 variants - Evolution, spike protein, and vaccines.
Chen KK; Tsung-Ning Huang D; Huang LM
Biomed J; 2022 Aug; 45(4):573-579. PubMed ID: 35526825
[TBL] [Abstract][Full Text] [Related]
9. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
10. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.
Peters MH; Bastidas O; Kokron DS; Henze CE
Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein.
Zhang S; Go EP; Ding H; Anang S; Kappes JC; Desaire H; Sodroski JG
J Virol; 2022 Feb; 96(3):e0162621. PubMed ID: 34817202
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies.
Almehdi AM; Khoder G; Alchakee AS; Alsayyid AT; Sarg NH; Soliman SSM
Infection; 2021 Oct; 49(5):855-876. PubMed ID: 34339040
[TBL] [Abstract][Full Text] [Related]
13. Molecular biology of the SARs-CoV-2 spike protein: A review of current knowledge.
Zhu C; He G; Yin Q; Zeng L; Ye X; Shi Y; Xu W
J Med Virol; 2021 Oct; 93(10):5729-5741. PubMed ID: 34125455
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
Hosoki K; Chakraborty A; Sur S
J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies.
Troyer Z; Alhusaini N; Tabler CO; Sweet T; de Carvalho KIL; Schlatzer DM; Carias L; King CL; Matreyek K; Tilton JC
J Extracell Vesicles; 2021 Jun; 10(8):e12112. PubMed ID: 34188786
[TBL] [Abstract][Full Text] [Related]
17. Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic.
Li X; Zhang L; Chen S; Ji W; Li C; Ren L
Infect Genet Evol; 2021 Sep; 93():104971. PubMed ID: 34146731
[TBL] [Abstract][Full Text] [Related]
18. From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19?
Pavan M; Bassani D; Sturlese M; Moro S
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1704-1714. PubMed ID: 35695095
[TBL] [Abstract][Full Text] [Related]
19. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.
Lim H; Baek A; Kim J; Kim MS; Liu J; Nam KY; Yoon J; No KT
Sci Rep; 2020 Oct; 10(1):16862. PubMed ID: 33033344
[TBL] [Abstract][Full Text] [Related]
20. In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2.
Jafary F; Jafari S; Ganjalikhany MR
Sci Rep; 2021 Mar; 11(1):6927. PubMed ID: 33767306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
